Biolife Solutions (BLFS) Net Income towards Common Stockholders (2016 - 2025)
Biolife Solutions (BLFS) has disclosed Net Income towards Common Stockholders for 16 consecutive years, with $7.5 million as the latest value for Q4 2025.
- On a quarterly basis, Net Income towards Common Stockholders fell 37.28% to $7.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $7.1 million, a 147.03% increase, with the full-year FY2025 number at $7.5 million, up 166.1% from a year prior.
- Net Income towards Common Stockholders was $7.5 million for Q4 2025 at Biolife Solutions, up from -$448000.0 in the prior quarter.
- In the past five years, Net Income towards Common Stockholders ranged from a high of $12.0 million in Q4 2024 to a low of -$72.9 million in Q2 2022.
- A 5-year average of -$11.1 million and a median of -$8.8 million in 2022 define the central range for Net Income towards Common Stockholders.
- Peak YoY movement for Net Income towards Common Stockholders: crashed 13159.49% in 2022, then surged 189.78% in 2024.
- Biolife Solutions' Net Income towards Common Stockholders stood at -$15.7 million in 2021, then crashed by 212.41% to -$49.2 million in 2022, then surged by 72.79% to -$13.4 million in 2023, then soared by 189.78% to $12.0 million in 2024, then crashed by 37.28% to $7.5 million in 2025.
- Per Business Quant, the three most recent readings for BLFS's Net Income towards Common Stockholders are $7.5 million (Q4 2025), -$448000.0 (Q1 2025), and $12.0 million (Q4 2024).